Biomaterial Injection Combines T Cell and Cancer Vaccine Treatments
August 7, 2023
Researchers at the Harvard Wyss Institute have developed an anti-cancer biomaterial treatment that combines adoptive T cell therapy and cancer vaccine technology to treat solid...
Conn Hastings
Cells with Backpacks to Treat Multiple Sclerosis
May 2, 2023
Researchers at the Harvard Wyss Institute have developed a new type of cell therapy for multiple sclerosis patients. The technique involves taking a blood sample...
Ovarian Organoids to Study Reproductive Health
February 28, 2023
Researchers at the Harvard Wyss Institute are collaborating with a biotechnology company called Gameto to develop human ovarian organoids that will allow the study of...
Personalized CAR-T Cell Therapy
February 17, 2023
Researchers at the Harvard Wyss Institute and the Dana-Farber Cancer Institute have developed a new method to prepare chimeric antigen receptor-T cells (CAR-T cells) for...
Implantable Device Adheres to Muscle, Treats Atrophy
November 16, 2022
Scientists at the Wyss Institute for Biologically Inspired Engineering at Harvard have developed a mechanically active gel-elastomer-nitinol tissue adhesive, otherwise known as MAGENTA. The implantable...
Microfluidic Chip Models Inflammatory Intestinal Disease
July 5, 2022
Researchers at Harvard’s Wyss Institute have modeled Environmental Enteric Dysfunction (EED), a childhood inflammatory intestinal disease, on a microfluidic chip and gained new insights into...